Stephens Cuts OraSure (OSUR) Stock To a Equal-Weight Rating

July 16, 2018 - By Carolyn Hewitt

Investors sentiment increased to 1.08 in Q1 2018. Its up 0.25, from 0.83 in 2017Q4. It increased, as 15 investors sold OraSure Technologies, Inc. shares while 57 reduced holdings. 29 funds opened positions while 49 raised stakes. 54.02 million shares or 0.43% more from 53.79 million shares in 2017Q4 were reported.

Ameritas Ptnrs reported 0% in OraSure Technologies, Inc. (NASDAQ:OSUR). The New Jersey-based Systematic Financial Mngmt Ltd Partnership has invested 0.03% in OraSure Technologies, Inc. (NASDAQ:OSUR). Gilder Gagnon Howe Co Ltd Liability Corporation has 0.01% invested in OraSure Technologies, Inc. (NASDAQ:OSUR). Janney Montgomery Scott Ltd Llc accumulated 10,039 shares. Bb&T Corporation invested in 0% or 10,053 shares. 14,693 are held by Ls Invest Advsrs Ltd Liability Company. Thompson Davis And Commerce Inc reported 0.01% stake. Fred Alger Management Inc stated it has 1.66M shares or 0.13% of all its holdings. Envestnet Asset Mgmt holds 0% of its portfolio in OraSure Technologies, Inc. (NASDAQ:OSUR) for 69 shares. State Teachers Retirement System has 0% invested in OraSure Technologies, Inc. (NASDAQ:OSUR) for 47,895 shares. The Missouri-based Parkside Retail Bank And Trust has invested 0% in OraSure Technologies, Inc. (NASDAQ:OSUR). Tci Wealth Advsr stated it has 0% in OraSure Technologies, Inc. (NASDAQ:OSUR). Secor Advsrs L P reported 41,648 shares. Adams Diversified Equity Fund has invested 0.03% in OraSure Technologies, Inc. (NASDAQ:OSUR). Virginia Retirement Et Al reported 27,500 shares.

Since February 15, 2018, it had 0 insider buys, and 2 insider sales for $778,707 activity. The insider TANG STEPHEN S PHD sold 23,333 shares worth $419,247.

OraSure (OSUR) Receives a Downgrade

In an analyst report shared with investors and clients on Monday morning, Stephens has decided to decreased rating on OraSure (OSUR) shares to a Equal-Weight. OSUR’s prior rating was a Overweight.

The stock decreased 5.27% or $0.911 during the last trading session, reaching $16.389. About 955,800 shares traded or 85.09% up from the average. OraSure Technologies, Inc. (OSUR) has risen 9.53% since July 16, 2017 and is uptrending. It has underperformed by 3.04% the S&P500.

Analysts await OraSure Technologies, Inc. (NASDAQ:OSUR) to report earnings on August, 1. They expect $0.04 EPS, down 55.56 % or $0.05 from last year’s $0.09 per share. OSUR’s profit will be $2.44 million for 102.43 P/E if the $0.04 EPS becomes a reality. After $-0.03 actual EPS reported by OraSure Technologies, Inc. for the previous quarter, Wall Street now forecasts -233.33 % EPS growth.

OraSure Technologies, Inc., together with its subsidiaries, develops, makes, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company has market cap of $1.00 billion. It operates in two divisions, OSUR and DNAG. It has a 60.03 P/E ratio. The firm also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests.

More important recent OraSure Technologies, Inc. (NASDAQ:OSUR) news were published by: Seekingalpha.com which released: “Premarket analyst action – healthcare” on July 16, 2018, also Nasdaq.com published article titled: “4 Top Ranked Momentum Stocks to Buy for June 20th”, Benzinga.com published: “31 Stocks Moving In Monday’s Mid-Day Session” on July 16, 2018. More interesting news about OraSure Technologies, Inc. (NASDAQ:OSUR) was released by: Profitconfidential.com and their article: “OraSure Technologies Stock: Long-Term Prospects Look Great” with publication date: June 25, 2018.

OraSure Technologies, Inc. (NASDAQ:OSUR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.